Industry Research Reports

Home > Reports > Medical Devices & Consumables > Inhaled Nitric Oxide Delivery Device - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Inhaled Nitric Oxide Delivery Device - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Medical Devices & Consumables

Published: 2024-01-11

Pages: 129 Pages

Report ld: 2638953

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

The global market for Inhaled Nitric Oxide Delivery Device was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

North American market for Inhaled Nitric Oxide Delivery Device was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Inhaled Nitric Oxide Delivery Device was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Inhaled Nitric Oxide Delivery Device was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Inhaled Nitric Oxide Delivery Device include Mallinckrodt Pharmaceuticals, Getinge, Vero Biotech, LINDE, Beyond Air, Air Liquide Healthcare, Circassia Pharmaceuticals, NU MED and Bellerophon Therapeutics, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Inhaled Nitric Oxide Delivery Device, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Inhaled Nitric Oxide Delivery Device by region & country, by Type, and by Application.

The Inhaled Nitric Oxide Delivery Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inhaled Nitric Oxide Delivery Device.

Market Segmentation

Report Metric
Details
Report Title
Inhaled Nitric Oxide Delivery Device - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Global Inhaled Nitric Oxide Delivery Device Companies Covered
Mallinckrodt Pharmaceuticals, Getinge, Vero Biotech, LINDE, Beyond Air, Air Liquide Healthcare, Circassia Pharmaceuticals, NU MED, Bellerophon Therapeutics, Praxair Technology Inc.
Global Inhaled Nitric Oxide Delivery Device Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Inhaled Nitric Oxide Delivery Device Market, Segment by Type
Inhaled Nitric Oxide Delivery Device for Children

Inhaled Nitric Oxide Delivery Device for Adults
Global Inhaled Nitric Oxide Delivery Device Market, Segment by Application
Hypoxic Respiratory Failure (HRF)

Acute Hypoxemic Respiratory Failure (AHRF)

Chronic Obstructive Pulmonary Disease (COPD)

Others
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Inhaled Nitric Oxide Delivery Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Inhaled Nitric Oxide Delivery Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Inhaled Nitric Oxide Delivery Device in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

 1 Market Overview
    1.1 Inhaled Nitric Oxide Delivery Device Product Introduction
    1.2 Global Inhaled Nitric Oxide Delivery Device Market Size Forecast
        1.2.1 Global Inhaled Nitric Oxide Delivery Device Sales Value (2019-2030)
        1.2.2 Global Inhaled Nitric Oxide Delivery Device Sales Volume (2019-2030)
        1.2.3 Global Inhaled Nitric Oxide Delivery Device Sales Price (2019-2030)
    1.3 Inhaled Nitric Oxide Delivery Device Market Trends & Drivers
        1.3.1 Inhaled Nitric Oxide Delivery Device Industry Trends
        1.3.2 Inhaled Nitric Oxide Delivery Device Market Drivers & Opportunity
        1.3.3 Inhaled Nitric Oxide Delivery Device Market Challenges
        1.3.4 Inhaled Nitric Oxide Delivery Device Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Inhaled Nitric Oxide Delivery Device Players Revenue Ranking (2023)
    2.2 Global Inhaled Nitric Oxide Delivery Device Revenue by Company (2019-2024)
    2.3 Global Inhaled Nitric Oxide Delivery Device Players Sales Volume Ranking (2023)
    2.4 Global Inhaled Nitric Oxide Delivery Device Sales Volume by Company Players (2019-2024)
    2.5 Global Inhaled Nitric Oxide Delivery Device Average Price by Company (2019-2024)
    2.6 Key Manufacturers Inhaled Nitric Oxide Delivery Device Manufacturing Base Distribution and Headquarters
    2.7 Key Manufacturers Inhaled Nitric Oxide Delivery Device Product Offered
    2.8 Key Manufacturers Time to Begin Mass Production of Inhaled Nitric Oxide Delivery Device
    2.9 Inhaled Nitric Oxide Delivery Device Market Competitive Analysis
        2.9.1 Inhaled Nitric Oxide Delivery Device Market Concentration Rate (2019-2024)
        2.9.2 Global 5 and 10 Largest Manufacturers by Inhaled Nitric Oxide Delivery Device Revenue in 2023
        2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inhaled Nitric Oxide Delivery Device as of 2023)
    2.10 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Inhaled Nitric Oxide Delivery Device for Children
        3.1.2 Inhaled Nitric Oxide Delivery Device for Adults
    3.2 Global Inhaled Nitric Oxide Delivery Device Sales Value by Type
        3.2.1 Global Inhaled Nitric Oxide Delivery Device Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Inhaled Nitric Oxide Delivery Device Sales Value, by Type (2019-2030)
        3.2.3 Global Inhaled Nitric Oxide Delivery Device Sales Value, by Type (%) (2019-2030)
    3.3 Global Inhaled Nitric Oxide Delivery Device Sales Volume by Type
        3.3.1 Global Inhaled Nitric Oxide Delivery Device Sales Volume by Type (2019 VS 2023 VS 2030)
        3.3.2 Global Inhaled Nitric Oxide Delivery Device Sales Volume, by Type (2019-2030)
        3.3.3 Global Inhaled Nitric Oxide Delivery Device Sales Volume, by Type (%) (2019-2030)
    3.4 Global Inhaled Nitric Oxide Delivery Device Average Price by Type (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Hypoxic Respiratory Failure (HRF)
        4.1.2 Acute Hypoxemic Respiratory Failure (AHRF)
        4.1.3 Chronic Obstructive Pulmonary Disease (COPD)
        4.1.4 Others
    4.2 Global Inhaled Nitric Oxide Delivery Device Sales Value by Application
        4.2.1 Global Inhaled Nitric Oxide Delivery Device Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Inhaled Nitric Oxide Delivery Device Sales Value, by Application (2019-2030)
        4.2.3 Global Inhaled Nitric Oxide Delivery Device Sales Value, by Application (%) (2019-2030)
    4.3 Global Inhaled Nitric Oxide Delivery Device Sales Volume by Application
        4.3.1 Global Inhaled Nitric Oxide Delivery Device Sales Volume by Application (2019 VS 2023 VS 2030)
        4.3.2 Global Inhaled Nitric Oxide Delivery Device Sales Volume, by Application (2019-2030)
        4.3.3 Global Inhaled Nitric Oxide Delivery Device Sales Volume, by Application (%) (2019-2030)
    4.4 Global Inhaled Nitric Oxide Delivery Device Average Price by Application (2019-2030)

 5 Segmentation by Region
    5.1 Global Inhaled Nitric Oxide Delivery Device Sales Value by Region
        5.1.1 Global Inhaled Nitric Oxide Delivery Device Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Inhaled Nitric Oxide Delivery Device Sales Value by Region (2019-2024)
        5.1.3 Global Inhaled Nitric Oxide Delivery Device Sales Value by Region (2025-2030)
        5.1.4 Global Inhaled Nitric Oxide Delivery Device Sales Value by Region (%), (2019-2030)
    5.2 Global Inhaled Nitric Oxide Delivery Device Sales Volume by Region
        5.2.1 Global Inhaled Nitric Oxide Delivery Device Sales Volume by Region: 2019 VS 2023 VS 2030
        5.2.2 Global Inhaled Nitric Oxide Delivery Device Sales Volume by Region (2019-2024)
        5.2.3 Global Inhaled Nitric Oxide Delivery Device Sales Volume by Region (2025-2030)
        5.2.4 Global Inhaled Nitric Oxide Delivery Device Sales Volume by Region (%), (2019-2030)
    5.3 Global Inhaled Nitric Oxide Delivery Device Average Price by Region (2019-2030)
    5.4 North America
        5.4.1 North America Inhaled Nitric Oxide Delivery Device Sales Value, 2019-2030
        5.4.2 North America Inhaled Nitric Oxide Delivery Device Sales Value by Country (%), 2023 VS 2030
    5.5 Europe
        5.5.1 Europe Inhaled Nitric Oxide Delivery Device Sales Value, 2019-2030
        5.5.2 Europe Inhaled Nitric Oxide Delivery Device Sales Value by Country (%), 2023 VS 2030
    5.6 Asia Pacific
        5.6.1 Asia Pacific Inhaled Nitric Oxide Delivery Device Sales Value, 2019-2030
        5.6.2 Asia Pacific Inhaled Nitric Oxide Delivery Device Sales Value by Country (%), 2023 VS 2030
    5.7 South America
        5.7.1 South America Inhaled Nitric Oxide Delivery Device Sales Value, 2019-2030
        5.7.2 South America Inhaled Nitric Oxide Delivery Device Sales Value by Country (%), 2023 VS 2030
    5.8 Middle East & Africa
        5.8.1 Middle East & Africa Inhaled Nitric Oxide Delivery Device Sales Value, 2019-2030
        5.8.2 Middle East & Africa Inhaled Nitric Oxide Delivery Device Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Inhaled Nitric Oxide Delivery Device Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Inhaled Nitric Oxide Delivery Device Sales Value
        6.2.1 Key Countries/Regions Inhaled Nitric Oxide Delivery Device Sales Value, 2019-2030
        6.2.2 Key Countries/Regions Inhaled Nitric Oxide Delivery Device Sales Volume, 2019-2030
    6.3 United States
        6.3.1 United States Inhaled Nitric Oxide Delivery Device Sales Value, 2019-2030
        6.3.2 United States Inhaled Nitric Oxide Delivery Device Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Inhaled Nitric Oxide Delivery Device Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Inhaled Nitric Oxide Delivery Device Sales Value, 2019-2030
        6.4.2 Europe Inhaled Nitric Oxide Delivery Device Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Inhaled Nitric Oxide Delivery Device Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Inhaled Nitric Oxide Delivery Device Sales Value, 2019-2030
        6.5.2 China Inhaled Nitric Oxide Delivery Device Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Inhaled Nitric Oxide Delivery Device Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Inhaled Nitric Oxide Delivery Device Sales Value, 2019-2030
        6.6.2 Japan Inhaled Nitric Oxide Delivery Device Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Inhaled Nitric Oxide Delivery Device Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Inhaled Nitric Oxide Delivery Device Sales Value, 2019-2030
        6.7.2 South Korea Inhaled Nitric Oxide Delivery Device Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Inhaled Nitric Oxide Delivery Device Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Inhaled Nitric Oxide Delivery Device Sales Value, 2019-2030
        6.8.2 Southeast Asia Inhaled Nitric Oxide Delivery Device Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Inhaled Nitric Oxide Delivery Device Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Inhaled Nitric Oxide Delivery Device Sales Value, 2019-2030
        6.9.2 India Inhaled Nitric Oxide Delivery Device Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Inhaled Nitric Oxide Delivery Device Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Mallinckrodt Pharmaceuticals
        7.1.1 Mallinckrodt Pharmaceuticals Company Information
        7.1.2 Mallinckrodt Pharmaceuticals Introduction and Business Overview
        7.1.3 Mallinckrodt Pharmaceuticals Inhaled Nitric Oxide Delivery Device Sales, Revenue and Gross Margin (2019-2024)
        7.1.4 Mallinckrodt Pharmaceuticals Inhaled Nitric Oxide Delivery Device Product Offerings
        7.1.5 Mallinckrodt Pharmaceuticals Recent Development
    7.2 Getinge
        7.2.1 Getinge Company Information
        7.2.2 Getinge Introduction and Business Overview
        7.2.3 Getinge Inhaled Nitric Oxide Delivery Device Sales, Revenue and Gross Margin (2019-2024)
        7.2.4 Getinge Inhaled Nitric Oxide Delivery Device Product Offerings
        7.2.5 Getinge Recent Development
    7.3 Vero Biotech
        7.3.1 Vero Biotech Company Information
        7.3.2 Vero Biotech Introduction and Business Overview
        7.3.3 Vero Biotech Inhaled Nitric Oxide Delivery Device Sales, Revenue and Gross Margin (2019-2024)
        7.3.4 Vero Biotech Inhaled Nitric Oxide Delivery Device Product Offerings
        7.3.5 Vero Biotech Recent Development
    7.4 LINDE
        7.4.1 LINDE Company Information
        7.4.2 LINDE Introduction and Business Overview
        7.4.3 LINDE Inhaled Nitric Oxide Delivery Device Sales, Revenue and Gross Margin (2019-2024)
        7.4.4 LINDE Inhaled Nitric Oxide Delivery Device Product Offerings
        7.4.5 LINDE Recent Development
    7.5 Beyond Air
        7.5.1 Beyond Air Company Information
        7.5.2 Beyond Air Introduction and Business Overview
        7.5.3 Beyond Air Inhaled Nitric Oxide Delivery Device Sales, Revenue and Gross Margin (2019-2024)
        7.5.4 Beyond Air Inhaled Nitric Oxide Delivery Device Product Offerings
        7.5.5 Beyond Air Recent Development
    7.6 Air Liquide Healthcare
        7.6.1 Air Liquide Healthcare Company Information
        7.6.2 Air Liquide Healthcare Introduction and Business Overview
        7.6.3 Air Liquide Healthcare Inhaled Nitric Oxide Delivery Device Sales, Revenue and Gross Margin (2019-2024)
        7.6.4 Air Liquide Healthcare Inhaled Nitric Oxide Delivery Device Product Offerings
        7.6.5 Air Liquide Healthcare Recent Development
    7.7 Circassia Pharmaceuticals
        7.7.1 Circassia Pharmaceuticals Company Information
        7.7.2 Circassia Pharmaceuticals Introduction and Business Overview
        7.7.3 Circassia Pharmaceuticals Inhaled Nitric Oxide Delivery Device Sales, Revenue and Gross Margin (2019-2024)
        7.7.4 Circassia Pharmaceuticals Inhaled Nitric Oxide Delivery Device Product Offerings
        7.7.5 Circassia Pharmaceuticals Recent Development
    7.8 NU MED
        7.8.1 NU MED Company Information
        7.8.2 NU MED Introduction and Business Overview
        7.8.3 NU MED Inhaled Nitric Oxide Delivery Device Sales, Revenue and Gross Margin (2019-2024)
        7.8.4 NU MED Inhaled Nitric Oxide Delivery Device Product Offerings
        7.8.5 NU MED Recent Development
    7.9 Bellerophon Therapeutics
        7.9.1 Bellerophon Therapeutics Company Information
        7.9.2 Bellerophon Therapeutics Introduction and Business Overview
        7.9.3 Bellerophon Therapeutics Inhaled Nitric Oxide Delivery Device Sales, Revenue and Gross Margin (2019-2024)
        7.9.4 Bellerophon Therapeutics Inhaled Nitric Oxide Delivery Device Product Offerings
        7.9.5 Bellerophon Therapeutics Recent Development
    7.10 Praxair Technology Inc.
        7.10.1 Praxair Technology Inc. Company Information
        7.10.2 Praxair Technology Inc. Introduction and Business Overview
        7.10.3 Praxair Technology Inc. Inhaled Nitric Oxide Delivery Device Sales, Revenue and Gross Margin (2019-2024)
        7.10.4 Praxair Technology Inc. Inhaled Nitric Oxide Delivery Device Product Offerings
        7.10.5 Praxair Technology Inc. Recent Development

 8 Industry Chain Analysis
    8.1 Inhaled Nitric Oxide Delivery Device Industrial Chain
    8.2 Inhaled Nitric Oxide Delivery Device Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Inhaled Nitric Oxide Delivery Device Sales Model
        8.5.2 Sales Channel
        8.5.3 Inhaled Nitric Oxide Delivery Device Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Inhaled Nitric Oxide Delivery Device Market Trends
    Table 2. Inhaled Nitric Oxide Delivery Device Market Drivers & Opportunity
    Table 3. Inhaled Nitric Oxide Delivery Device Market Challenges
    Table 4. Inhaled Nitric Oxide Delivery Device Market Restraints
    Table 5. Global Inhaled Nitric Oxide Delivery Device Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Inhaled Nitric Oxide Delivery Device Revenue Market Share by Company (2019-2024)
    Table 7. Global Inhaled Nitric Oxide Delivery Device Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Inhaled Nitric Oxide Delivery Device Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Inhaled Nitric Oxide Delivery Device Price by Company (2019-2024) & (US$/Unit)
    Table 10. Key Manufacturers Inhaled Nitric Oxide Delivery Device Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Inhaled Nitric Oxide Delivery Device Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Inhaled Nitric Oxide Delivery Device
    Table 13. Global Inhaled Nitric Oxide Delivery Device Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inhaled Nitric Oxide Delivery Device as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Inhaled Nitric Oxide Delivery Device Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Inhaled Nitric Oxide Delivery Device Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Inhaled Nitric Oxide Delivery Device Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Inhaled Nitric Oxide Delivery Device Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Inhaled Nitric Oxide Delivery Device Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Inhaled Nitric Oxide Delivery Device Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Inhaled Nitric Oxide Delivery Device Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Inhaled Nitric Oxide Delivery Device Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Inhaled Nitric Oxide Delivery Device Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Inhaled Nitric Oxide Delivery Device Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Inhaled Nitric Oxide Delivery Device Price by Type (2019-2024) & (US$/Unit)
    Table 27. Global Inhaled Nitric Oxide Delivery Device Price by Type (2025-2030) & (US$/Unit)
    Table 28. Global Inhaled Nitric Oxide Delivery Device Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Inhaled Nitric Oxide Delivery Device Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Inhaled Nitric Oxide Delivery Device Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Inhaled Nitric Oxide Delivery Device Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Inhaled Nitric Oxide Delivery Device Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Inhaled Nitric Oxide Delivery Device Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Inhaled Nitric Oxide Delivery Device Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Inhaled Nitric Oxide Delivery Device Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Inhaled Nitric Oxide Delivery Device Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Inhaled Nitric Oxide Delivery Device Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Inhaled Nitric Oxide Delivery Device Price by Application (2019-2024) & (US$/Unit)
    Table 39. Global Inhaled Nitric Oxide Delivery Device Price by Application (2025-2030) & (US$/Unit)
    Table 40. Global Inhaled Nitric Oxide Delivery Device Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Inhaled Nitric Oxide Delivery Device Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Inhaled Nitric Oxide Delivery Device Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Inhaled Nitric Oxide Delivery Device Sales Value by Region (2019-2024) & (%)
    Table 44. Global Inhaled Nitric Oxide Delivery Device Sales Value by Region (2025-2030) & (%)
    Table 45. Global Inhaled Nitric Oxide Delivery Device Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Inhaled Nitric Oxide Delivery Device Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Inhaled Nitric Oxide Delivery Device Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Inhaled Nitric Oxide Delivery Device Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Inhaled Nitric Oxide Delivery Device Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Inhaled Nitric Oxide Delivery Device Average Price by Region (2019-2024) & (US$/Unit)
    Table 51. Global Inhaled Nitric Oxide Delivery Device Average Price by Region (2025-2030) & (US$/Unit)
    Table 52. Key Countries/Regions Inhaled Nitric Oxide Delivery Device Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Inhaled Nitric Oxide Delivery Device Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Inhaled Nitric Oxide Delivery Device Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Inhaled Nitric Oxide Delivery Device Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Inhaled Nitric Oxide Delivery Device Sales Volume, (2025-2030) & (K Units)
    Table 57. Mallinckrodt Pharmaceuticals Company Information
    Table 58. Mallinckrodt Pharmaceuticals Introduction and Business Overview
    Table 59. Mallinckrodt Pharmaceuticals Inhaled Nitric Oxide Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 60. Mallinckrodt Pharmaceuticals Inhaled Nitric Oxide Delivery Device Product Offerings
    Table 61. Mallinckrodt Pharmaceuticals Recent Development
    Table 62. Getinge Company Information
    Table 63. Getinge Introduction and Business Overview
    Table 64. Getinge Inhaled Nitric Oxide Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 65. Getinge Inhaled Nitric Oxide Delivery Device Product Offerings
    Table 66. Getinge Recent Development
    Table 67. Vero Biotech Company Information
    Table 68. Vero Biotech Introduction and Business Overview
    Table 69. Vero Biotech Inhaled Nitric Oxide Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 70. Vero Biotech Inhaled Nitric Oxide Delivery Device Product Offerings
    Table 71. Vero Biotech Recent Development
    Table 72. LINDE Company Information
    Table 73. LINDE Introduction and Business Overview
    Table 74. LINDE Inhaled Nitric Oxide Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 75. LINDE Inhaled Nitric Oxide Delivery Device Product Offerings
    Table 76. LINDE Recent Development
    Table 77. Beyond Air Company Information
    Table 78. Beyond Air Introduction and Business Overview
    Table 79. Beyond Air Inhaled Nitric Oxide Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 80. Beyond Air Inhaled Nitric Oxide Delivery Device Product Offerings
    Table 81. Beyond Air Recent Development
    Table 82. Air Liquide Healthcare Company Information
    Table 83. Air Liquide Healthcare Introduction and Business Overview
    Table 84. Air Liquide Healthcare Inhaled Nitric Oxide Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 85. Air Liquide Healthcare Inhaled Nitric Oxide Delivery Device Product Offerings
    Table 86. Air Liquide Healthcare Recent Development
    Table 87. Circassia Pharmaceuticals Company Information
    Table 88. Circassia Pharmaceuticals Introduction and Business Overview
    Table 89. Circassia Pharmaceuticals Inhaled Nitric Oxide Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 90. Circassia Pharmaceuticals Inhaled Nitric Oxide Delivery Device Product Offerings
    Table 91. Circassia Pharmaceuticals Recent Development
    Table 92. NU MED Company Information
    Table 93. NU MED Introduction and Business Overview
    Table 94. NU MED Inhaled Nitric Oxide Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 95. NU MED Inhaled Nitric Oxide Delivery Device Product Offerings
    Table 96. NU MED Recent Development
    Table 97. Bellerophon Therapeutics Company Information
    Table 98. Bellerophon Therapeutics Introduction and Business Overview
    Table 99. Bellerophon Therapeutics Inhaled Nitric Oxide Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 100. Bellerophon Therapeutics Inhaled Nitric Oxide Delivery Device Product Offerings
    Table 101. Bellerophon Therapeutics Recent Development
    Table 102. Praxair Technology Inc. Company Information
    Table 103. Praxair Technology Inc. Introduction and Business Overview
    Table 104. Praxair Technology Inc. Inhaled Nitric Oxide Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 105. Praxair Technology Inc. Inhaled Nitric Oxide Delivery Device Product Offerings
    Table 106. Praxair Technology Inc. Recent Development
    Table 107. Key Raw Materials Lists
    Table 108. Raw Materials Key Suppliers Lists
    Table 109. Inhaled Nitric Oxide Delivery Device Downstream Customers
    Table 110. Inhaled Nitric Oxide Delivery Device Distributors List
    Table 111. Research Programs/Design for This Report
    Table 112. Key Data Information from Secondary Sources
    Table 113. Key Data Information from Primary Sources
List of Figures
    Figure 1. Inhaled Nitric Oxide Delivery Device Product Picture
    Figure 2. Global Inhaled Nitric Oxide Delivery Device Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Inhaled Nitric Oxide Delivery Device Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Inhaled Nitric Oxide Delivery Device Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Inhaled Nitric Oxide Delivery Device Sales Price (2019-2030) & (US$/Unit)
    Figure 6. Inhaled Nitric Oxide Delivery Device Report Years Considered
    Figure 7. Global Inhaled Nitric Oxide Delivery Device Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Inhaled Nitric Oxide Delivery Device Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Inhaled Nitric Oxide Delivery Device Revenue in 2023
    Figure 10. Inhaled Nitric Oxide Delivery Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Inhaled Nitric Oxide Delivery Device for Children Picture
    Figure 12. Inhaled Nitric Oxide Delivery Device for Adults Picture
    Figure 13. Global Inhaled Nitric Oxide Delivery Device Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Inhaled Nitric Oxide Delivery Device Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Global Inhaled Nitric Oxide Delivery Device Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 16. Global Inhaled Nitric Oxide Delivery Device Sales Volume Market Share by Type, 2023 & 2030
    Figure 17. Global Inhaled Nitric Oxide Delivery Device Price by Type (2019-2030) & (US$/Unit)
    Figure 18. Product Picture of Hypoxic Respiratory Failure (HRF)
    Figure 19. Product Picture of Acute Hypoxemic Respiratory Failure (AHRF)
    Figure 20. Product Picture of Chronic Obstructive Pulmonary Disease (COPD)
    Figure 21. Product Picture of Others
    Figure 22. Global Inhaled Nitric Oxide Delivery Device Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 23. Global Inhaled Nitric Oxide Delivery Device Sales Value Market Share by Application, 2023 & 2030
    Figure 24. Global Inhaled Nitric Oxide Delivery Device Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 25. Global Inhaled Nitric Oxide Delivery Device Sales Volume Market Share by Application, 2023 & 2030
    Figure 26. Global Inhaled Nitric Oxide Delivery Device Price by Application (2019-2030) & (US$/Unit)
    Figure 27. North America Inhaled Nitric Oxide Delivery Device Sales Value (2019-2030) & (US$ Million)
    Figure 28. North America Inhaled Nitric Oxide Delivery Device Sales Value by Country (%), 2023 VS 2030
    Figure 29. Europe Inhaled Nitric Oxide Delivery Device Sales Value (2019-2030) & (US$ Million)
    Figure 30. Europe Inhaled Nitric Oxide Delivery Device Sales Value by Country (%), 2023 VS 2030
    Figure 31. Asia Pacific Inhaled Nitric Oxide Delivery Device Sales Value (2019-2030) & (US$ Million)
    Figure 32. Asia Pacific Inhaled Nitric Oxide Delivery Device Sales Value by Country (%), 2023 VS 2030
    Figure 33. South America Inhaled Nitric Oxide Delivery Device Sales Value (2019-2030) & (US$ Million)
    Figure 34. South America Inhaled Nitric Oxide Delivery Device Sales Value by Country (%), 2023 VS 2030
    Figure 35. Middle East & Africa Inhaled Nitric Oxide Delivery Device Sales Value (2019-2030) & (US$ Million)
    Figure 36. Middle East & Africa Inhaled Nitric Oxide Delivery Device Sales Value by Country (%), 2023 VS 2030
    Figure 37. Key Countries/Regions Inhaled Nitric Oxide Delivery Device Sales Value (%), (2019-2030)
    Figure 38. Key Countries/Regions Inhaled Nitric Oxide Delivery Device Sales Volume (%), (2019-2030)
    Figure 39. United States Inhaled Nitric Oxide Delivery Device Sales Value, (2019-2030) & (US$ Million)
    Figure 40. United States Inhaled Nitric Oxide Delivery Device Sales Value by Type (%), 2023 VS 2030
    Figure 41. United States Inhaled Nitric Oxide Delivery Device Sales Value by Application (%), 2023 VS 2030
    Figure 42. Europe Inhaled Nitric Oxide Delivery Device Sales Value, (2019-2030) & (US$ Million)
    Figure 43. Europe Inhaled Nitric Oxide Delivery Device Sales Value by Type (%), 2023 VS 2030
    Figure 44. Europe Inhaled Nitric Oxide Delivery Device Sales Value by Application (%), 2023 VS 2030
    Figure 45. China Inhaled Nitric Oxide Delivery Device Sales Value, (2019-2030) & (US$ Million)
    Figure 46. China Inhaled Nitric Oxide Delivery Device Sales Value by Type (%), 2023 VS 2030
    Figure 47. China Inhaled Nitric Oxide Delivery Device Sales Value by Application (%), 2023 VS 2030
    Figure 48. Japan Inhaled Nitric Oxide Delivery Device Sales Value, (2019-2030) & (US$ Million)
    Figure 49. Japan Inhaled Nitric Oxide Delivery Device Sales Value by Type (%), 2023 VS 2030
    Figure 50. Japan Inhaled Nitric Oxide Delivery Device Sales Value by Application (%), 2023 VS 2030
    Figure 51. South Korea Inhaled Nitric Oxide Delivery Device Sales Value, (2019-2030) & (US$ Million)
    Figure 52. South Korea Inhaled Nitric Oxide Delivery Device Sales Value by Type (%), 2023 VS 2030
    Figure 53. South Korea Inhaled Nitric Oxide Delivery Device Sales Value by Application (%), 2023 VS 2030
    Figure 54. Southeast Asia Inhaled Nitric Oxide Delivery Device Sales Value, (2019-2030) & (US$ Million)
    Figure 55. Southeast Asia Inhaled Nitric Oxide Delivery Device Sales Value by Type (%), 2023 VS 2030
    Figure 56. Southeast Asia Inhaled Nitric Oxide Delivery Device Sales Value by Application (%), 2023 VS 2030
    Figure 57. India Inhaled Nitric Oxide Delivery Device Sales Value, (2019-2030) & (US$ Million)
    Figure 58. India Inhaled Nitric Oxide Delivery Device Sales Value by Type (%), 2023 VS 2030
    Figure 59. India Inhaled Nitric Oxide Delivery Device Sales Value by Application (%), 2023 VS 2030
    Figure 60. Inhaled Nitric Oxide Delivery Device Industrial Chain
    Figure 61. Inhaled Nitric Oxide Delivery Device Manufacturing Cost Structure
    Figure 62. Channels of Distribution (Direct Sales, and Distribution)
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed

Description

The global market for Inhaled Nitric Oxide Delivery Device was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

North American market for Inhaled Nitric Oxide Delivery Device was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Inhaled Nitric Oxide Delivery Device was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Inhaled Nitric Oxide Delivery Device was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Inhaled Nitric Oxide Delivery Device include Mallinckrodt Pharmaceuticals, Getinge, Vero Biotech, LINDE, Beyond Air, Air Liquide Healthcare, Circassia Pharmaceuticals, NU MED and Bellerophon Therapeutics, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Inhaled Nitric Oxide Delivery Device, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Inhaled Nitric Oxide Delivery Device by region & country, by Type, and by Application.

The Inhaled Nitric Oxide Delivery Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inhaled Nitric Oxide Delivery Device.

Market Segmentation